Related Experiment Video

Updated: Aug 25, 2026

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
10:12

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis

Published on: September 11, 2019

Hepatitis C and HIV infection: biological, clinical, and therapeutic implications

V Soriano1, J Garcìa-Samaniego, R Rodrìguez-Rosado

  • 1Service of Infectious Diseases, Hospital Carlos III, Instituto de Salud Carlos III Madrid, Spain. vsoriano@dragonet.es

Journal of Hepatology
|January 6, 2000
PubMed

Insights

Liver disease is a growing concern for individuals with HIV and hepatitis C co-infection, particularly among intravenous drug users. Combination therapy shows promising results for sustained response and safety in these patients.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Immunology

Background:

  • Liver disease is an increasing cause of morbidity and mortality in HIV-HCV co-infected individuals.
  • Intravenous drug users and hemophiliacs represent high-risk populations for HIV-HCV co-infection.
  • Hepatotoxicity risk is elevated with anti-HIV medications in patients with chronic hepatitis C.

Purpose of the Study:

  • To evaluate the efficacy and safety of antiviral therapies in HIV-HCV co-infected patients.
  • To assess the impact of liver disease as a cause of hospitalization and death in the context of declining AIDS mortality.
  • To explore treatment options for HIV-HCV co-infection, considering the specific challenges in immunosuppressed populations.

Main Methods:

  • Review of clinical data on HIV-HCV co-infected patients.
  • Analysis of treatment outcomes with alpha-interferon monotherapy.
  • Evaluation of preliminary results from combination therapy trials (interferon plus ribavirin).

Main Results:

  • Alpha-interferon shows comparable response rates in non-severely immunosuppressed HIV-positive and HIV-negative individuals.
  • Preliminary data suggest promising sustained response rates with interferon plus ribavirin combination therapy.
  • The combination therapy demonstrated a favorable safety profile in initial trials for HIV-HCV co-infection.

Conclusions:

  • Liver disease management is critical in the evolving landscape of HIV care.
  • Combination therapy with interferon and ribavirin presents a promising therapeutic strategy for HIV-HCV co-infection.
  • Further research is warranted to optimize treatment protocols for this vulnerable patient group.

More Related Videos

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...